On Feb. 24, the FDA approved revisions to the safety labeling for nevirapine tablets and oral suspension (Viramune, made by Boehringer Ingelheim Pharmaceuticals, Inc) to warn of the risk of ...
A Mount Sinai School of Medicine researcher reported results from a study with a drug combination that showed the highest hepatitis C treatment response rates ever reported in patients infected with ...
Roche announced that the U.S. Food and Drug Administration (FDA) has approved combination therapy with Pegasys (peginterferon alfa-2a), a pegylated interferon, and Copegus (ribavirin) for the ...
ZURICH (MarketWatch) -- Swiss pharmaceutical company Roche Holding AG (RHHBY) and Chugai Pharmaceutical Co. (4519.TO) said Friday a combination of Copegus and Pegasys has been approved in Japan for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results